Caspian Journal of Internal Medicine
Babol University of Medical Sciences
سه شنبه 28 اسفند 1403
[Archive]
دوره 4، شماره 3 - ( 10-1391 )
جلد 4 شماره 3 صفحات 730-727 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mahmoodi Nesheli H, Hadizadeh A, Bijani A. Evaluation of inhibitor antibodies in haemophilia A population. Caspian J Intern Med 2013; 4 (3) :727-730
URL: http://caspjim.com/article-1-212-fa.html
URL: http://caspjim.com/article-1-212-fa.html
Evaluation of inhibitor antibodies in haemophilia A population. . 1391; 4 (3) :727-730
چکیده: (7830 مشاهده)
Background: Inhibitory antibody to exogenous Factor VIII (FVIII) is a major complication of hemophilia treatment. This study was conducted to determine the prevalence of inhibitor antibody directed against FVIII.
Methods: From May 2010 to May 2011, 52 patients with severe hemophilia A admitted in Amirkola Children’s Hospital were evaluated. Those who had abnormal mixing study, antibody against FVIII were measured. Data were collected and analyzed.
Results: The age range of the patients was 4-60 years. The inhibitor antibody was seen in 9 (17.3%) patients. The mean age of patients with inhibitor at the time of diagnosis was 10.22 years (ranged 4-31 years). Old patients had more hemarthrosis than young patients. The mean level of inhibitor antibody was 8.47 Bethesda (ranged 2.3-29). Six patients had inhibitor antibody level ?5 Bethesda unit and three patients had inhibitor antibody level<5 Bethesda unit.
Conclusion: This study showed that the prevalence of inhibitor antibody in young patients is more than the old patients.
Methods: From May 2010 to May 2011, 52 patients with severe hemophilia A admitted in Amirkola Children’s Hospital were evaluated. Those who had abnormal mixing study, antibody against FVIII were measured. Data were collected and analyzed.
Results: The age range of the patients was 4-60 years. The inhibitor antibody was seen in 9 (17.3%) patients. The mean age of patients with inhibitor at the time of diagnosis was 10.22 years (ranged 4-31 years). Old patients had more hemarthrosis than young patients. The mean level of inhibitor antibody was 8.47 Bethesda (ranged 2.3-29). Six patients had inhibitor antibody level ?5 Bethesda unit and three patients had inhibitor antibody level<5 Bethesda unit.
Conclusion: This study showed that the prevalence of inhibitor antibody in young patients is more than the old patients.
نوع مطالعه: Original Article |
موضوع مقاله:
Infectious Diseases
دریافت: 1392/10/27 | پذیرش: 1392/10/27 | انتشار: 1392/10/27
دریافت: 1392/10/27 | پذیرش: 1392/10/27 | انتشار: 1392/10/27
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
